• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

延迟钆增强定量在收缩功能障碍的肥厚型心肌病心脏磁共振成像中的预后意义

Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.

作者信息

Funada Akira, Kanzaki Hideaki, Noguchi Teruo, Morita Yoshiaki, Sugano Yasuo, Ohara Takahiro, Hasegawa Takuya, Hashimura Hiromi, Ishibashi-Ueda Hatsue, Kitakaze Masafumi, Yasuda Satoshi, Ogawa Hisao, Anzai Toshihisa

机构信息

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565, Japan.

Department of Radiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

出版信息

Heart Vessels. 2016 May;31(5):758-70. doi: 10.1007/s00380-015-0670-4. Epub 2015 Mar 28.

DOI:10.1007/s00380-015-0670-4
PMID:25820658
Abstract

Hypertrophic cardiomyopathy (HCM) with systolic dysfunction carries a poor prognosis. Although late gadolinium enhancement (LGE) on cardiac magnetic resonance is associated with adverse cardiac events in HCM and is inversely related to left ventricular ejection fraction (LVEF), it is unknown whether LGE or LVEF more accurately predicts adverse cardiac events in HCM with systolic dysfunction. We retrospectively assessed the extent of LGE with a threshold of 6 standard deviations in 46 consecutive HCM patients with systolic dysfunction defined as LVEF <50 % (average 35 ± 12 %) who underwent cardiac magnetic resonance (35 males, mean age 59 ± 14 years). They were followed up over 1755 ± 594 days. The composite adverse cardiac events end point included cardiovascular death, lethal arrhythmia, cardioembolic stroke, and unplanned heart failure hospitalization. LGE was detected in all patients, and the mean extent was 30 ± 15 %. Twenty-nine patients developed adverse cardiac events. Multivariate Cox proportional hazard analysis revealed the extent of LGE as a good independent predictor of adverse cardiac events. Risk increased with the extent of LGE (hazard ratio = 1.62/10 % increase in LGE, 95 % confidence interval = 1.23-2.15, p < 0.001). LVEF was inversely related to the extent of LGE (r = -0.44; p = 0.002) and was also an independent predictor of adverse cardiac events. Risk decreased with LVEF (hazard ratio = 0.68/10 % increase in LVEF, 95 % confidence interval = 0.51-0.91, p = 0.010). The Akaike information criterion evaluating the fit of a model demonstrated that the extent of LGE was a better independent predictor of MACE than LVEF (Akaike information criterion = 172.20 and 178.09, respectively).The extent of LGE was a good independent predictor of adverse cardiac events and reflected mortality and morbidity more precisely than LVEF in HCM with systolic dysfunction.

摘要

伴有收缩功能障碍的肥厚型心肌病(HCM)预后较差。尽管心脏磁共振成像上的晚期钆增强(LGE)与HCM的不良心脏事件相关,且与左心室射血分数(LVEF)呈负相关,但尚不清楚LGE或LVEF能否更准确地预测伴有收缩功能障碍的HCM的不良心脏事件。我们回顾性评估了46例连续的伴有收缩功能障碍的HCM患者的LGE范围,这些患者的收缩功能障碍定义为LVEF<50%(平均35±12%),均接受了心脏磁共振成像检查(35例男性,平均年龄59±14岁)。对他们进行了1755±594天的随访。复合不良心脏事件终点包括心血管死亡、致死性心律失常、心源性栓塞性中风和非计划性心力衰竭住院。所有患者均检测到LGE,平均范围为30±15%。29例患者发生了不良心脏事件。多因素Cox比例风险分析显示LGE范围是不良心脏事件的良好独立预测指标。风险随LGE范围增加而增加(风险比=1.62/ LGE每增加10%,95%置信区间=1.23 - 2.15,p<0.001)。LVEF与LGE范围呈负相关(r=-0.44;p=0.002),也是不良心脏事件的独立预测指标。风险随LVEF降低(风险比=0.68/ LVEF每增加10%,95%置信区间=0.51 - 0.91,p=0.010)。评估模型拟合优度的赤池信息准则表明,LGE范围比LVEF是主要不良心血管事件更好的独立预测指标(赤池信息准则分别为172.20和178.09)。在伴有收缩功能障碍的HCM中,LGE范围是不良心脏事件的良好独立预测指标,比LVEF更能准确反映死亡率和发病率。

相似文献

1
Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.延迟钆增强定量在收缩功能障碍的肥厚型心肌病心脏磁共振成像中的预后意义
Heart Vessels. 2016 May;31(5):758-70. doi: 10.1007/s00380-015-0670-4. Epub 2015 Mar 28.
2
The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.CMR 评估的 LVEF、晚期钆增强和整体圆周应变的联合增量预后价值。
JACC Cardiovasc Imaging. 2015 May;8(5):540-549. doi: 10.1016/j.jcmg.2015.02.005. Epub 2015 Apr 15.
3
Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.肥厚型心肌病的收缩期和舒张期心肌力学及其与肥厚程度、替代性纤维化和间质纤维化的关系。
Int J Cardiovasc Imaging. 2015 Dec;31(8):1603-10. doi: 10.1007/s10554-015-0720-0. Epub 2015 Jul 26.
4
LGE-CMR-derived texture features reflect poor prognosis in hypertrophic cardiomyopathy patients with systolic dysfunction: preliminary results.基于 LGE-CMR 的纹理特征反映收缩功能障碍的肥厚型心肌病患者预后不良:初步结果。
Eur Radiol. 2018 Nov;28(11):4615-4624. doi: 10.1007/s00330-018-5391-5. Epub 2018 May 4.
5
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.应用三维斑点追踪超声心动图研究心肌整体和局部力学与肥厚型心肌病心肌肥厚和纤维化的关系。
Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25.
6
CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.终末期肥厚型心肌病伴或不伴心室重构的心脏磁共振成像评估及临床结局
Int J Cardiovasc Imaging. 2018 Apr;34(4):597-605. doi: 10.1007/s10554-017-1263-3. Epub 2017 Oct 25.
7
Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.延迟钆增强在非缺血性心肌病中的预后价值。
Am J Cardiol. 2016 Oct 1;118(7):1063-8. doi: 10.1016/j.amjcard.2016.06.059. Epub 2016 Jul 18.
8
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.3.0 T磁共振心肌灌注成像用于肥厚型心肌病冠状动脉微血管功能障碍的半定量评估
Int J Cardiovasc Imaging. 2017 Dec;33(12):1949-1959. doi: 10.1007/s10554-017-1189-9. Epub 2017 Jun 13.
9
The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.肥厚型心肌病患者延迟钆增强磁共振与非持续室性心动过速负荷的关系:一项延迟对比增强磁共振研究。
J Cardiovasc Electrophysiol. 2019 May;30(5):651-657. doi: 10.1111/jce.13855. Epub 2019 Feb 2.
10
Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.心脏磁共振成像和半乳糖凝集素-3水平作为非缺血性心肌病患者预后结果的预测指标
Int J Cardiovasc Imaging. 2016 Dec;32(12):1725-1733. doi: 10.1007/s10554-016-0958-1. Epub 2016 Aug 26.

引用本文的文献

1
Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy.延迟钆增强熵作为评估肥厚型心肌病患者心肌组织异质性的新指标,用于预测不良心脏事件。
Insights Imaging. 2023 Aug 21;14(1):138. doi: 10.1186/s13244-023-01479-6.
2
Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis.比较心血管磁共振成像心肌纤维化定量方法在疑似心肌炎患者危险分层中的作用。
J Cardiovasc Magn Reson. 2019 Feb 28;21(1):14. doi: 10.1186/s12968-019-0520-0.
3

本文引用的文献

1
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
2
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.定量对比增强心血管磁共振对肥厚型心肌病患者猝死风险评估的预后价值。
Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
3
2D speckle-tracking TTE-based quantitative classification of left ventricular myocardium in patients with hypertrophic cardiomyopathy by the presence or the absence of fibrosis and/or hypertrophy.
基于二维斑点追踪经胸超声心动图(2D speckle-tracking TTE),根据有无纤维化和/或肥厚对肥厚型心肌病患者左心室心肌进行定量分类。
Heart Vessels. 2018 Sep;33(9):1046-1051. doi: 10.1007/s00380-018-1155-z. Epub 2018 Mar 22.
4
Characteristic systolic waveform of left ventricular longitudinal strain rate in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者左心室纵向应变率的特征性收缩期波形。
Heart Vessels. 2017 May;32(5):591-599. doi: 10.1007/s00380-016-0906-y. Epub 2016 Oct 18.
5
T wave amplitude in lead aVR as a novel diagnostic marker for cardiac sarcoidosis.aVR导联T波振幅作为心脏结节病的一种新型诊断标志物。
Heart Vessels. 2017 Mar;32(3):352-358. doi: 10.1007/s00380-016-0881-3. Epub 2016 Jul 27.
6
Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.慢性心力衰竭患者心脏磁共振成像上的延迟钆增强可预测冠状动脉血管舒缩异常及心肌乳酸生成。
Heart Vessels. 2016 Dec;31(12):1969-1979. doi: 10.1007/s00380-016-0816-z. Epub 2016 Feb 18.
7
Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation.与心外膜双极标测图相比,心内膜单极标测图中较大的低电压区表明通过导管消融消除室性心动过速存在困难。
Heart Vessels. 2016 Aug;31(8):1337-46. doi: 10.1007/s00380-015-0732-7. Epub 2015 Aug 13.
8
Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease.对于稳定型冠状动脉疾病患者,SYNTAX评分对延迟钆增强磁共振成像的增量预后价值。
Heart Vessels. 2016 Jun;31(6):871-80. doi: 10.1007/s00380-015-0685-x. Epub 2015 Apr 23.
Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
心血管磁共振成像上广泛的延迟钆增强可预测心脏结节病患者接受类固醇治疗后的不良结局以及左心室功能改善情况欠佳。
Heart. 2014 Aug;100(15):1165-72. doi: 10.1136/heartjnl-2013-305187. Epub 2014 May 14.
4
In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.肥厚型心肌病弥漫性心肌纤维化的体内 T1 心血管磁共振研究。
J Cardiovasc Magn Reson. 2014 Apr 25;16(1):28. doi: 10.1186/1532-429X-16-28.
5
Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging in Japanese hypertrophic cardiomyopathy patients.心脏磁共振成像延迟钆增强对日本肥厚型心肌病患者的预后价值。
Circ J. 2014;78(4):929-37. doi: 10.1253/circj.cj-13-0979. Epub 2014 Feb 13.
6
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.植入式心脏复律除颤器在肥厚型心肌病中的应用:患者结局、恰当和不恰当干预的发生率以及并发症。
Am Heart J. 2013 Sep;166(3):496-502. doi: 10.1016/j.ahj.2013.06.009. Epub 2013 Jul 16.
7
Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.遗传性心血管疾病的当前观点:从基础到临床方面
Heart Vessels. 2014 Mar;29(2):129-41. doi: 10.1007/s00380-013-0391-5. Epub 2013 Aug 2.
8
Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.肥厚型心肌病中的心肌纤维化:CMR 对组织病理学发现的准确反映。
JACC Cardiovasc Imaging. 2013 May;6(5):587-96. doi: 10.1016/j.jcmg.2012.09.018. Epub 2013 Apr 10.
9
Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.心肌肥厚型和扩张型心肌病中正常心肌与弥漫性病变的 T1 自然映射鉴别。
JACC Cardiovasc Imaging. 2013 Apr;6(4):475-84. doi: 10.1016/j.jcmg.2012.08.019. Epub 2013 Mar 14.
10
Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.心脏肌钙蛋白T基因的突变在日本肥厚型心肌病患者中显示出不同的预后。
Heart Vessels. 2013 Nov;28(6):785-94. doi: 10.1007/s00380-013-0332-3. Epub 2013 Mar 14.